BiotechTube
Home/Targepeutics/Randy Schrecengost, PhD
RS

Randy Schrecengost, PhD

Chief Scientific Officer

Targepeutics

Therapeutic Areas

OncologyNeuro-Oncology

Targepeutics Pipeline

DrugIndicationPhase
GB-13Glioblastoma (GBM) and Diffuse Midline Glioma (DMG)Pre-clinical

Leadership Team at Targepeutics

SL
Sil Lutkewitte
CEO, Chair - Board of Directors
LM
Lynn Maines, PhD
Co-founder, Business Development and Operations Advisor
View full Targepeutics profile